Feasibility and safety of hyperthermic intraperitoneal chemotherapy using 5‐fluorouracil combined with cisplatin and mitomycin C in patients undergoing gastrectomy for advanced gastric cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-9098|116|8|1159-1165

ISSN： 0022-4790

Source： JOURNAL OF SURGICAL ONCOLOGY, Vol.116, Iss.8, 2017-12, pp. : 1159-1165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Early Postoperative Intraperitoneal Chemotherapy with Mitomycin C, 5-Fluorouracil and Cisplatin for Advanced Gastric Cancer

By  

Oncology, Vol. 60, Iss. 1, 2000-12 ,pp. : 24-30

Karger

Access to resources Recommend Favorite

Mitomycin C, 5-Fluorouracil, Leucovorin, and Oxaliplatin as a Salvage Therapy for Patients with Cisplatin-Resistant Advanced Gastric Cancer: A Phase I Dose Escalation Trial

By  

Oncology Research and Treatment, Vol. 30, Iss. 1-2, 2007-01 ,pp. : 29-34

Karger

Access to resources Recommend Favorite

Feasibility of Preoperative Chemotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil versus Adriamycin, Cisplatin, and 5-Fluorouracil for Resectable Advanced Esophageal Cancer

By  

Oncology, Vol. 92, Iss. 2, 2016-12 ,pp. : 101-108

Karger

Access to resources Recommend Favorite

Beneficial Effects of 5-Fluorouracil and Heparin-Based Portal Infusion Chemotherapy Combined with Mitomycin C and Cisplatin after Curative Resection of Pancreatic Cancer

By  

Pancreatology, Vol. 10, Iss. 2-3, 2010-05 ,pp. : 250-258

Karger

Access to resources Recommend Favorite

Outcome of Infusional 5-Fluorouracil, Doxorubicin, and Mitomycin-C (iFAM) Chemotherapy and Analysis of Prognostic Factors in Patients with Refractory Advanced Biliary Tract Cancer

By  

Oncology, Vol. 83, Iss. 2, 2012-06 ,pp. : 57-66

Karger

Access to resources Recommend Favorite